Autophagy regulates cellular senescence by mediating the degradation of CDKN1A/p21 and CDKN2A/p16 through SQSTM1/p62-mediated selective autophagy in myxomatous mitral valve degeneration
Open Access
- 4 March 2025
- journal article
- Published by Taylor & Francis in Autophagy
- Vol. 21 (7) , 1433-1455
Abstract
Myxomatous mitral valve degeneration (MMVD) is one of the most important age-dependent degenerative heart valve disorders in both humans and dogs. It is characterized by the aberrant remodeling of extracellular matrix (ECM), regulated by senescent myofibroblasts (aVICs) transitioning from quiescent valve interstitial cells (qVICs), primarily under TGFB1/TGF-β1 control. In the present study, we found senescent aVICs exhibited impaired macroautophagy/autophagy as evidenced by compromised autophagy flux and immature autophagosomes. MTOR-dependent autophagy induced by rapamycin and torin-1 attenuated cell senescence and decreased the expression of cyclin-dependent kinase inhibitors (CDKIs) CDKN2A/p16INK4A and CDKN1A/p21CIP1. Furthermore, induction of autophagy in aVICs by ATG (autophagy related) gene overexpression restored autophagy flux, with a concomitant reduction in CDKN1A and CDKN2A expression and senescence-associated secretory phenotype (SASP). Conversely, autophagy deficiency induced CDKN1A and CDKN2A accumulation and SASP, whereas ATG re-expression alleviated senescent phenotypic transformation. Notably, CDKN1A and CDKN2A localized to autophagosomes and lysosomes following MTOR antagonism or MG132 treatment. SQSTM1/p62 was identified as the autophagy receptor to selectively sequester CDKN1A and CDKN2A cargoes for autophagic degradation. Our findings are the first demonstration that CDKN1A and CDKN2A are degraded through SQSTM1-mediated selective autophagy, independent of the ubiquitin-proteasome pathway. These data will inform development of therapeutic strategies for the treatment of canine and human MMVD, and for the treatment of Alzheimer disease, Parkinson disease and other age-related degenerative disorders.Keywords
Funding Information
- CavalierHealth.org
- Health Foundation
- Biotechnology and Biological Sciences Research Council (BBS/E/D/10002071)
- Creative Commons
This publication has 88 references indexed in Scilit:
- Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanismsCardiovascular Pathology, 2020
- Biological Functions of Autophagy Genes: A Disease PerspectiveCell, 2019
- The Mitral Annulus Disjunction Arrhythmic SyndromeJACC, 2018
- Inhibition of PI3K/AKT/mTOR signaling pathway promotes autophagy of articular chondrocytes and attenuates inflammatory response in rats with osteoarthritisBiomedicine & Pharmacotherapy, 2017
- TGF-beta1 pathway activation and adherens junction molecular pattern in nonsyndromic mitral valve prolapseCardiovascular Pathology, 2015
- Cardiac fibroblasts: from development to heart failureJournal of Molecular Medicine, 2015
- Clearance of misfolded and aggregated proteins by aggrephagy and implications for aggregation diseasesAgeing Research Reviews, 2014
- Rapamycin: One Drug, Many EffectsCell Metabolism, 2014
- Methods to Detect Biomarkers of Cellular Senescence2007
- Subcellular localization, modification and protein complex formation of the cdk‐inhibitor p16 in Rb‐functional and Rb‐inactivated tumor cellsInternational Journal of Cancer, 2005